Halo-Bio granted Tekmira exclusive, worldwide rights to multivalent RNAi (MV-RNA) technology

Halo-Bio RNAi Therapeutics Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Tekmira Pharmaceuticals Corp.

Canada / Small-Cap Biopharma (<$1 billion)

$23.6m on 08/26/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced